Study type: In vitro · Status: Verified against declared source

Modulation of innate immunity related genes resulting in prophylactic antimicrobial and antiviral properties.

Journal of translational medicine · 2024

Study scale: Solution-3 inhibits FLU-A and RSV-A propagation.

Product or molecular entity relationships

LL-37: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

Plain-language verified summary

Question

Therefore, two different therapeutic time windows must be considered in the clinical management of the immunopathological viral response.

Methods

The online version contains supplementary material available at 10.1186/s12967-024-05378-2.

Scale or participants

Solution-3 inhibits FLU-A and RSV-A propagation.

Key findings

The microbial co-infection from virus, bacteria and fungi exacerbates the difficulties of treatment and prognosis of COVID-19 patients [4].

Limitations and uncertainty

RSV infection usually begins with infected cells releasing new virions nearby healthy cells and then results in cell fusion mechanisms thus resulting in multinucleated cells called syncytia [89, 90].

Verified against declared source. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.